Equities Analysts Issue Forecasts for AARD FY2024 Earnings
Aardvark Therapeutics, Inc. (NASDAQ:AARD – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for Aardvark Therapeutics in a report released on Monday, March 10th. Cantor Fitzgerald analyst J. Schimmer expects that the company will post earnings per share of ($3.89) for the year. Cantor Fitzgerald has […]
Aardvark Therapeutics, Inc. (NASDAQ:AARD – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for Aardvark Therapeutics in a report released on Monday, March 10th. Cantor Fitzgerald analyst J. Schimmer expects that the company will post earnings per share of ($3.89) for the year. Cantor Fitzgerald has […]
